Tokyo Tape
Sign in
← OLBA Healthcare Holdings

Quarterly report · Q1

2689.TEDINET S100PJIX
Period2022-07-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥26.3bn2022-07-01 → 2022-09-30Cons.Net sales
Revenue¥108.0bn2021-07-01 → 2022-06-30Cons.Net sales (5-year summary)
Revenue¥25.0bn2021-07-01 → 2021-09-30Cons.Net sales
Operating income¥403m2022-07-01 → 2022-09-30Cons.Operating income
Operating income¥249m2021-07-01 → 2021-09-30Cons.Operating income
Ordinary income¥404m2022-07-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥2.1bn2021-07-01 → 2022-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥257m2021-07-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥402m2022-07-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥242m2021-07-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥251m2022-07-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2021-07-01 → 2022-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥175m2021-07-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥251m2022-07-01 → 2022-09-30Cons.Profit loss
Net income¥175m2021-07-01 → 2021-09-30Cons.Profit loss
Total assets¥38.5bnat 2022-09-30Cons.Assets
Total assets¥40.0bnat 2022-06-30Cons.Assets
Total assets¥38.3bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥29.5bnat 2022-09-30Cons.Liabilities
Total liabilities¥30.9bnat 2022-06-30Cons.Liabilities
Net assets / equity¥9.0bnat 2022-09-30Cons.Net assets
Net assets / equity¥9.1bnat 2022-06-30Cons.Net assets
Net assets / equity¥8.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.2bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥3.2bnat 2022-06-30Cons.Cash and deposits
EPS (basic)¥41.842022-07-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥252.82021-07-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥28.812021-07-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio23.3%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio22.8%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio20.9%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-09-30−¥394m
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-09-30−¥394m
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-09-30−¥38m
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentrevenue2022-07-01 → 2022-09-30¥616m
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentrevenue external2022-07-01 → 2022-09-30¥616m
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥23,000
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentsegment profit2022-07-01 → 2022-09-30¥47m
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentrevenue2022-07-01 → 2022-09-30¥24.8bn
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentrevenue external2022-07-01 → 2022-09-30¥24.5bn
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥363m
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentsegment profit2022-07-01 → 2022-09-30¥347m
jpcrp040300-q1r_E02928-000SPDreportable segmentrevenue2022-07-01 → 2022-09-30¥1.2bn
jpcrp040300-q1r_E02928-000SPDreportable segmentrevenue external2022-07-01 → 2022-09-30¥1.2bn
jpcrp040300-q1r_E02928-000SPDreportable segmentrevenue intersegment2022-07-01 → 2022-09-30¥32m
jpcrp040300-q1r_E02928-000SPDreportable segmentsegment profit2022-07-01 → 2022-09-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-07-01 → 2022-09-30¥26.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-07-01 → 2022-09-30¥26.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-07-01 → 2022-09-30¥394m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2022-09-30¥441m
Reconciling Itemsreconcilingrevenue2021-07-01 → 2021-09-30−¥342m
Reconciling Itemsreconcilingrevenue intersegment2021-07-01 → 2021-09-30−¥342m
Reconciling Itemsreconcilingsegment profit2021-07-01 → 2021-09-30−¥48m
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentrevenue2021-07-01 → 2021-09-30¥582m
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentrevenue external2021-07-01 → 2021-09-30¥582m
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥14,000
jpcrp040300-q1r_E02928-000Care Nursing Goodsreportable segmentsegment profit2021-07-01 → 2021-09-30¥39m
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentrevenue2021-07-01 → 2021-09-30¥23.6bn
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentrevenue external2021-07-01 → 2021-09-30¥23.3bn
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥311m
jpcrp040300-q1r_E02928-000Medical Equipmentreportable segmentsegment profit2021-07-01 → 2021-09-30¥231m
jpcrp040300-q1r_E02928-000SPDreportable segmentrevenue2021-07-01 → 2021-09-30¥1.2bn
jpcrp040300-q1r_E02928-000SPDreportable segmentrevenue external2021-07-01 → 2021-09-30¥1.1bn
jpcrp040300-q1r_E02928-000SPDreportable segmentrevenue intersegment2021-07-01 → 2021-09-30¥31m
jpcrp040300-q1r_E02928-000SPDreportable segmentsegment profit2021-07-01 → 2021-09-30¥28m
Total Of Reportable Segments And Otherssegment totalrevenue2021-07-01 → 2021-09-30¥25.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-07-01 → 2021-09-30¥25.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-07-01 → 2021-09-30¥342m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-07-01 → 2021-09-30¥298m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 354
ItemContextValueUnit
Net defined benefit liabilityPrior1YearInstant435912000JPY
Net defined benefit liabilityCurrentQuarterInstant430634000JPY
Long term accounts payable otherPrior1YearInstant278127000JPY
Long term accounts payable otherCurrentQuarterInstant203502000JPY
Other nclPrior1YearInstant1027590000JPY
Other nclCurrentQuarterInstant1044127000JPY
Noncurrent liabilitiesPrior1YearInstant2009258000JPY
Noncurrent liabilitiesCurrentQuarterInstant1892594000JPY
LiabilitiesPrior1YearInstant30875365000JPY
LiabilitiesCurrentQuarterInstant29548820000JPY
Capital stockPrior1YearInstant607750000JPY
Capital stockCurrentQuarterInstant607750000JPY
Capital surplusPrior1YearInstant315704000JPY
Capital surplusCurrentQuarterInstant321534000JPY
Retained earningsPrior1YearInstant8369369000JPY
Retained earningsCurrentQuarterInstant8253695000JPY
Treasury stockPrior1YearInstant-375903000JPY
Treasury stockCurrentQuarterInstant-374018000JPY
Shareholders equityPrior1YearInstant8916919000JPY
Shareholders equityCurrentQuarterInstant8808961000JPY
Valuation difference on available for sale securitiesPrior1YearInstant121157000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant121027000JPY
Remeasurements of defined benefit plansPrior1YearInstant55229000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant52873000JPY
Valuation and translation adjustmentsPrior1YearInstant176387000JPY
Valuation and translation adjustmentsCurrentQuarterInstant173900000JPY
Non controlling interestsPrior1YearInstant－JPY
Non controlling interestsCurrentQuarterInstant－JPY
Net assetsPrior1YearInstant9093306000JPY
Net assetsCurrentQuarterInstant8982861000JPY
Liabilities and net assetsPrior1YearInstant39968672000JPY
Liabilities and net assetsCurrentQuarterInstant38531682000JPY
Net salesPrior1YTDDuration25013186000JPY
Net salesCurrentYTDDuration26307999000JPY
Cost of salesPrior1YTDDuration22199192000JPY
Cost of salesCurrentYTDDuration23272437000JPY
Gross profitPrior1YTDDuration2813993000JPY
Gross profitCurrentYTDDuration3035561000JPY
Selling general and administrative expensesPrior1YTDDuration2564514000JPY
Selling general and administrative expensesCurrentYTDDuration2632145000JPY
Operating incomePrior1YTDDuration249479000JPY
Operating incomeCurrentYTDDuration403416000JPY
Interest income noiPrior1YTDDuration107000JPY
Interest income noiCurrentYTDDuration8000JPY
Insurance income noiPrior1YTDDuration6830000JPY
Insurance income noiCurrentYTDDuration6000JPY
Commission fee noiPrior1YTDDuration4763000JPY
Commission fee noiCurrentYTDDuration1194000JPY
Electricity sale income noiPrior1YTDDuration2143000JPY
Electricity sale income noiCurrentYTDDuration2947000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-06-30pass rounding
balance sheet identityconsolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-07-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-07-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-06-30pass
statement vs summary · total assetsconsolidated 2022-09-30pass